Active, not recruiting
TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT06664983
- Conditions
- Nasopharyngeal Cancinoma (NPC)
- Locations
-
- SunYat-senU Guangzhou, Guangdong, China